Clinical Trials Logo

Sentinel Lymph Node Biopsy clinical trials

View clinical trials related to Sentinel Lymph Node Biopsy.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03833960 Completed - Clinical trials for Sentinel Lymph Node Biopsy

SLNB After Neoadjuvant Treatment in Node Positive Patients

Start date: May 2016
Phase:
Study type: Observational

From May 2016 till May 2018 all breast cancer patients with operable disease submitted to surgery after neoadjuvant treatment would be divided in four groups considering initially clinical axillary stage, axillary procedure that was done, axillary response to preoperative systemic treatment and pathological axillary stage. In first postoperative year all patients will be monitored for appearance of locoregional and distant recurrence.

NCT ID: NCT03200704 Completed - Breast Cancer Clinical Trials

A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer

FILM-B
Start date: January 4, 2019
Phase: Phase 3
Study type: Interventional

This is a prospective, open label, multicenter, non-inferiority within-patient study to determine the effectiveness of IC2000 (Indocyanine Green (ICG) for Injection) and the SPY Portable Handheld Imaging System (SPY-PHI) as an intraoperative fluorescence visualization tool, in the visual identification of lymphatic vessels and lymph nodes (LNs) during lymphatic mapping and sentinel lymph node biopsy (SLNB) procedures as confirmed by Technitium99m (Tc99m) and Gamma Probe.